A Study to Compare the Effectiveness and Safety of T1695 Versus Ciclosporin in Participants With Moderate to Severe Vernal Keratoconjunctivitis

NCT07169695 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Moderate to Severe Vernal Keratoconjunctivitis

Interventions

DIAGNOSTIC_TEST: Slit Lamp Examination
DIAGNOSTIC_TEST: Far Best Corrected Visual Acuity (BCVA)
DRUG: T1695
DRUG: Ciclosporin
DIAGNOSTIC_TEST: Corneal fluorescein staining score on modified Oxford scale

Sponsor

Laboratoires Thea